UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

Impaired dopamine metabolism in Parkinson's disease pathogenesis

Molecular neurodegeneration, 2019-08, Vol.14 (1), p.35-35, Article 35

2019

Link zum Volltext

Verfügbarkeit prüfen

Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?

Biomolecules (Basel, Switzerland), 2020-01, Vol.10 (2), p.195

2020

Link zum Volltext

Verfügbarkeit prüfen

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges

International journal of molecular sciences, 2021-12, Vol.23 (1), p.398

2021

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 as a target for modulating immune system responses

Neurobiology of disease, 2022-07, Vol.169, p.105724-105724, Article 105724

2022

Link zum Volltext

Verfügbarkeit prüfen

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

PloS one, 2013, Vol.8 (1), p.e55375-e55375

2013

Link zum Volltext

Verfügbarkeit prüfen

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View

Current neuropharmacology, 2016-04, Vol.14 (3), p.260-271

2016

Link zum Volltext

Verfügbarkeit prüfen

Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease

Neurobiology of disease, 2017-12, Vol.108, p.65-72

2017

Link zum Volltext

Verfügbarkeit prüfen

Ceramides in Parkinson's Disease: From Recent Evidence to New Hypotheses

Frontiers in neuroscience, 2019-04, Vol.13, p.330-330

2019

Link zum Volltext

Verfügbarkeit prüfen

Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease

Journal of neurochemistry, 2021-08, Vol.158 (4), p.833-836

2021

Link zum Volltext

Verfügbarkeit prüfen

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson's disease

NPJ Parkinson's Disease, 2022-03, Vol.8 (1), p.32-32, Article 32

2022

Link zum Volltext

Verfügbarkeit prüfen

Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?

Biochemical Society transactions, 2017-02, Vol.45 (1), p.261

2017

Link zum Volltext

Verfügbarkeit prüfen

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Molecular neurobiology, 2021-07, Vol.58 (7), p.3119-3140

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils

Neurobiology of disease, 2019-09, Vol.129, p.67-78

2019

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

NPJ Parkinson's Disease, 2020, Vol.6 (1), p.18-18, Article 18

2020

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease

Frontiers in aging neuroscience, 2020-03, Vol.12, p.68-68

2020

Link zum Volltext

Verfügbarkeit prüfen

Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies

The FASEB journal, 2013-06, Vol.27 (6), p.2101-2110

2013

Link zum Volltext

Verfügbarkeit prüfen

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson's Disease

Antioxidants, 2023-01, Vol.12 (2), p.261

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation

PloS one, 2015-08, Vol.10 (8), p.e0136769-e0136769

2015

Link zum Volltext

Verfügbarkeit prüfen

USP14 inhibition corrects an in vivo model of impaired mitophagy

EMBO molecular medicine, 2018-11, Vol.10 (11), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4400

2020

Link zum Volltext

Verfügbarkeit prüfen

Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease

Current neuropharmacology, 2021, Vol.19 (10), p.1618-1639

2021

Link zum Volltext

Verfügbarkeit prüfen

Unsaturated Fatty Acid-Induced Conformational Transitions and Aggregation of the Repeat Domain of Tau

Molecules (Basel, Switzerland), 2020-06, Vol.25 (11), p.2716

2020

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson’s Disease

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6469

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective Effect of Antiapoptotic URG7 Protein on Human Neuroblastoma Cell Line SH-SY5Y

International journal of molecular sciences, 2023-12, Vol.25 (1), p.481

2023

Link zum Volltext

Verfügbarkeit prüfen

Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?

Current topics in medicinal chemistry, 2016-11, Vol.16 (27), p.3033

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(227)

Publikationsform

Sprache

Englisch
(234)
Japanisch
(26)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impaired dopamine metabolism in Parkinson's disease pathogenesis

Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges

LRRK2 as a target for modulating immune system responses

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View

Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease

Ceramides in Parkinson's Disease: From Recent Evidence to New Hypotheses

Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson's disease

Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease

Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson's Disease

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation

USP14 inhibition corrects an in vivo model of impaired mitophagy

Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies

Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease

Unsaturated Fatty Acid-Induced Conformational Transitions and Aggregation of the Repeat Domain of Tau

Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson’s Disease

Neuroprotective Effect of Antiapoptotic URG7 Protein on Human Neuroblastoma Cell Line SH-SY5Y

Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?

Suchergebnisse filtern